Doutoramento em Neurociências, pela Universidade do Minho, Portugal (2014).
Mestrado em Medicina Molecular pelo Imperial College London, Londres, Reino Unido (2011).
Licenciaturaem Biologia Molecular pela Universidade Azad, Irão.(2009).
Percurso Profissional
Fundadora e gerente: NeuroImprove Clinic, Porto (2015 - Presente).
Formadora: NeuroImprove Academy (2020 - Presente).
Investigadora: Hospital de Hammersmith, Imperial College London, Londres, Reino Unido (2010 - 2011).
Investigadora: Diabetes and bio-nanotechnology units in Endocrinology & Metabolism Research Institute (EMRI), Teerã, Irão (2008 - 2010).
Assistente médica e Diretora Técnica: White Complex laser clinic, Teerã, Irão (2002 - 2003).
Outras Certificações
Curso de formação inicial de formadores, pela Joviform (2020).
BCIA neurofeedback certification, BFE (Biofeedback Federation of Europe) 19th workshop, pela BCIA (2017).
Curso “Neurofeedback- 36 BCIA Didactic Hours”, pela New Mind Academy (2016).
Curso “Introductory course in Neurofeedback”, pelo Euibion (2015).
Curso “Fundamentals in neuroscience” Instituto de Investigação em Ciência da Vida e da Saúde (ICVS) pelo Universidade do Minho (2013).
Laboratory animal science, pelo ICVS, Universidade do Minho (2013).
Curso “Biostatistics in Health Sciences” pelo ICVS, Universidade do Minho (2012).
Publicações
J. Castelhano-Carlos, S. Aslani, N. Sousa (2020) The Impact of Physical Enrichment in the Structure of the Medial Prefrontal Cortex and Nucleus Accumbens of the Adult Male Rat Brain. Neuroscience. 454: (51-60).
Morais, J. Pereira, S. Aslani, et al, Joao M Besa (2016) The impact of antipsychotic drugs on behaviour: new perspectives from the methylazoxymethanol rodent model of schizophrenia. European Neuropsychopharmacology 26(2): S450-S451.
Aslani, N. Vieira, F. Marques, P.S. Costa, N. Sousa, J.A. Palha. (2015) The effect of obesity-inducing high fat diet on rat’s mood and feeding behavior and response to stress. Translational Psychiatry. 5 (684).
Aslani, M.R. Harb, P.S. Costa, O.F.X. Almeida, N. Sousa, J.A. Palha. (2013) Day and night: The diurnal phase influences the response to chronic mild stress. Frontiers in Behavioral Neuroscience. 8 (82): 1-8.
Mirzaei, A. Hossein-nezhad, S. Aslani, S. Emamgholipour, M. Karimi, S.A. Keshavarz. (2012). Energy Expenditure Regulation via Macrophage Migration Inhibitory Factor (MIF) in Obesity and In Vitro Anti-MIF Effect of Alpinia Officinarum Hance Extraction. Endocrine practice. 18(1): 30-48, PMID: 21803717.
Aslani, A. Hossein-nezhad, Z. Maghbooli, K. Mirzae, F. Karimi. (2011) Genetic variation in Macrophage migration inhibitory factor associated with Gestational Diabetes Mellitus and metabolic syndrome. Horm Metab Res. 43(8): 557- 561, PMID: 21512965.
Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, A.N. Afshar, F. Karimi. (2011). VDR FokI polymorphism and its potential role in the pathogenesis of Gestational Diabetes Mellitus and its complications. Gynecological Endocrinology, 27(12):1055-60, PMID: 21663527.
Aslani, A. Hossein-nezhad, K. Mirzae, Z. Maghbooli, S.N. Asgarabad, F. Karimi. (2011) Tandem repeats of the CATT element of macrophage migration inhibitory factor gene may predict GDM severity. European Journal of Inflammation, 9(2): 185-191.
Hossein-nezhad, K. Mirzaei, S. Aslani, A. Tootee, F. Karimi. (2011) MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correlation with resting metabolic rate in obesity. European Journal of Inflammation. 9(2): 125-134.
